Astec LifeSciences Limited has informed the Exchange about re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director of the Company for a second term of 5 (five) years commencing from 18th December, 2025 upto 17th December, 2030, subject to approval of the Shareholders.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences has informed the stock exchange about the re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director. This is his second term, lasting 5 years from 18th December 2025 to 17th December 2030. The appointment is subject to approval from shareholders at a general meeting. Mr. Dhekne will continue in his existing role on the board without any change in his designation or status.
This is a routine board governance announcement and does not materially impact shareholders or the stock price. It indicates continuity on the board, with shareholders getting a chance to approve the re-appointment.